Lercanidipine is a third-generation, lipophilic, brain-penetrant, vascular-selective, and orally active dihydropyridine-calcium channel blocker with a pIC50 of 7.74. It has a long-lasting antihypertensive action and also exhibits reno- and neuro-protective effects. Additionally, Lercanidipine demonstrates anti-oxidant, anti-inflammatory, and anti-apoptotic properties. It is suitable for cardiovascular and neurological research.
- Third-generation dihydropyridine-calcium channel blocker
- Lipophilic and brain-penetrant
- Vascular-selective and orally active
- Long-lasting antihypertensive action
- Reno- and neuro-protective effect
- Anti-oxidant, anti-inflammatory, and anti-apoptotic properties
- Can be used in cardiovascular and neurological research